Mod­er­na es­tab­lish­es pub­lic health-fo­cused char­i­ty; FDA ap­proves As­traZeneca di­a­betes drug for pe­di­atric use

To help pro­mote pub­lic health and health­care in un­der­served ar­eas of the world, Mod­er­na will es­tab­lish a char­i­ty with a $50 mil­lion en­dow­ment.

The Cam­bridge …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.